FDA Inspection
Pharbest Pharmaceuticals, Inc.Pharbest Pharmaceuticals, Inc. – FDA Inspection, Mar 17, 2011
Record Details
This FDA Inspection record concerns Pharbest Pharmaceuticals, Inc., with an inspection on March 17, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 17, 2011
- Product Type
- Drugs
View Company Profile
ID · e45c7787-864e-4a17-9dc1-f980792a3217
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 713990
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)(2)In-process materials - sampling, testing procedures
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharbest Pharmaceuticals, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2025 | VAI | New York District Office | Drug Quality Assurance |
| November 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 3, 2021 | VAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| April 18, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 8, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharbest Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.